User contributions for Lazy

From Glioblastoma Treatments
A user with 453 edits. Account created on 16 March 2024.
Jump to navigationJump to search
Search for contributionsExpandCollapse
⧼contribs-top⧽
⧼contribs-date⧽
(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

13 June 2024

29 May 2024

27 May 2024

17 May 2024

  • 20:1220:12, 17 May 2024 diff hist +3,163 N Metronomic low dose temozolomide (TMZ)Created page with "{{TreatmentInfo |drug_name=Metronomic Low-Dose Temozolomide (TMZ) |FDA_approval=FDA-approved for glioblastoma but standard metronomic dosing is still under investigation |used_for=Glioblastoma Multiforme (GBM), recurrent GBM |clinical_trial_phase=Phase II and III for metronomic dosing schedules |common_side_effects=Nausea, vomiting, fatigue, myelosuppression, lymphopenia |OS_without=Median overall survival for GBM is typically 15-17 months from diagnosis |OS_with=Studies..." current
  • 10:0510:05, 17 May 2024 diff hist +356 HyperthermiaNo edit summary current
  • 10:0310:03, 17 May 2024 diff hist +1,629 N HyperthermiaCreated page with "{{TreatmentInfo |drug_name=Hyperthermia |FDA_approval=Investigational |used_for=Glioblastoma Multiforme (GBM) |clinical_trial_phase=Phase I/II |common_side_effects=Localized discomfort, potential damage to surrounding healthy tissue |OS_without=Standard progression statistics for GBM |OS_with=Extended survival reported in some clinical trials |PFS_without=Standard progression statistics for GBM |PFS_with=Improved progression-free survival in combination with other treatm..."

15 May 2024

28 April 2024

  • 11:0111:01, 28 April 2024 diff hist −4 Main Page→‎Alternative Therapies Targeting GSCs
  • 11:0011:00, 28 April 2024 diff hist −14 Main Page→‎Alternative Therapies Targeting GSCs
  • 10:5710:57, 28 April 2024 diff hist +3,025 N ParthenolideCreated page with "{{TreatmentInfo |drug_name=Parthenolide |FDA_approval=No (Used primarily in research settings; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment, specifically for its effects on glioblastoma and glioma stem cells |clinical_trial_phase=Preclinical studies |clinical_trial_explanation=Parthenolide is being studied for its potential anti-cancer properties in glioblastoma, particularly focusing on its ability to target and kill glioma st..." current
  • 10:5510:55, 28 April 2024 diff hist −21 MetforminNo edit summary current
  • 10:5310:53, 28 April 2024 diff hist +2,886 N MetforminCreated page with "{{TreatmentInfo |drug_name=Metformin |FDA_approval=Yes (Approved for type 2 diabetes; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment, specifically studied for effects on glioblastoma and glioma stem cells |clinical_trial_phase=Preclinical studies and some clinical trials |clinical_trial_explanation=Metformin is under investigation for its potential anti-cancer properties in glioblastoma, particularly its effects on glioma stem ce..."
  • 10:4910:49, 28 April 2024 diff hist +27 SulforaphaneNo edit summary current
  • 10:4710:47, 28 April 2024 diff hist +2,892 N SulforaphaneCreated page with "{{TreatmentInfo |drug_name=Sulforaphane |FDA_approval=No (Used as a dietary supplement; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment, particularly in preclinical studies focusing on glioblastoma |clinical_trial_phase=Preclinical studies |clinical_trial_explanation=Sulforaphane is being studied in preclinical models for its potential as an anti-cancer agent against glioblastoma. Research focuses on its ability to inhibit histone..."
  • 10:4610:46, 28 April 2024 diff hist +3,405 N ResveratrolCreated page with "{{TreatmentInfo |drug_name=Resveratrol |FDA_approval=No (Used as a dietary supplement; not FDA-approved for cancer treatment) |used_for=Investigational use in cancer treatment and prevention; also studied for cardiovascular benefits and anti-aging properties |clinical_trial_phase=Preclinical studies and early clinical trials |clinical_trial_explanation=Resveratrol is being studied for its potential anti-cancer properties in preclinical and early clinical trials, focusing..." current
(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)